Implanted cardioverter defibrillator (ICD) therapy in patients with suspected myocarditis: time of implantation and occurrence of ventricular arrhythmias

Back

EHRA Premium Access

Implanted cardioverter defibrillator (ICD) therapy in patients with suspected myocarditis: time of implantation and occurrence of ventricular arrhythmias

Session: Rapid Fire session 1 - ICD and prevention of sudden death

Topic: Primary prevention (Sudden cardiac death and implantable defibrillators)

Speaker: Doctor V. Pavlicek (Homburg, DE)

Event: EHRA EUROPACE - CARDIOSTIM 2017

Congress Presentation

Add to my library

About the speaker

Doctor Valerie Pavlicek

Saarland University Hospital, Homburg (Germany)

0 follower

7 more presentations in this session

Reappraisal of the value of electrophysiological study in sudden cardiac death risk stratification in hypertrophic cardiomyopathy

Speaker: Associate Professor K. Gatzoulis (Athens, GR)

Six year follow-up of the initial dutch subcutaneous implantable cardioverter-defibrillator cohort: Long term complications and battery longevity.

Speaker: Ms A. Quast (Amsterdam, NL)

Long-term follow-up of elderly implantable cardioverter-defibrillator patients

Speaker: Ms D. Yilmaz (Leiden, NL)

A comparison of clinical outcomes of subcutaneous and transvenous implantable defibrillator therapy in the SIMPLE and EFFORTLESS studies

Speaker: Doctor T. Brouwer (Amsterdam, NL)

Scar characterization to predict life-threateninG Arrhythmic events and sudden cardiac death in cardiac resynchronization therapy patients. The GAUDI-CRT study.

Speaker: Doctor J. Acosta Martinez (Seville, ES)

Access

Abstract

Access the full session

Rapid Fire session 1 - ICD and prevention of sudden death

Speakers: Doctor V. Pavlicek, Associate Professor K. Gatzoulis, Ms A. Quast, Ms D. Yilmaz, Doctor T. Brouwer...

Access

About the event

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources